Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
D000380:Agranulocytosis / Q000150:complications*; D000583:Amikacin / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D002513:Cephamycins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007612:Kanamycin / Q000031:analogs & derivatives*; D009070:Moxalactam; D010406:Penicillins / Q000627:therapeutic use*; D013982:Ticarcillin / Q000627:therapeutic use*
D002511:Cephalosporins; D002513:Cephamycins; D010406:Penicillins; D007612:Kanamycin; D000583:Amikacin; D013982:Ticarcillin; D009070:Moxalactam